Cargando…
Value of SERCA2a as a Biomarker for the Identification of Patients with Heart Failure Requiring Circulatory Support
Background: Heart failure (HF) alters the nucleo-cytoplasmic transport of cardiomyocytes and reduces SERCA2a levels, essential for intracellular calcium homeostasis. We consider in this study whether the molecules involved in these processes can differentiate those patients with advanced HF and the...
Autores principales: | Ezzitouny, Meryem, Roselló-Lletí, Esther, Portolés, Manuel, Sánchez-Lázaro, Ignacio, Arnau-Vives, Miguel Ángel, Tarazón, Estefanía, Gil-Cayuela, Carolina, Lozano-Edo, Silvia, López-Vilella, Raquel, Almenar-Bonet, Luis, Martínez-Dolz, Luis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8622248/ https://www.ncbi.nlm.nih.gov/pubmed/34834474 http://dx.doi.org/10.3390/jpm11111122 |
Ejemplares similares
-
Cardiac Allograft Rejection Induces Changes in Nucleocytoplasmic Transport: RANGAP1 as a Potential Non-Invasive Biomarker
por: Lozano-Edo, Silvia, et al.
Publicado: (2022) -
Implication of Sphingolipid Metabolism Gene Dysregulation and Cardiac Sphingosine-1-Phosphate Accumulation in Heart Failure
por: Pérez-Carrillo, Lorena, et al.
Publicado: (2022) -
TRPM7 is down‐regulated in both left atria and left ventricle of ischaemic cardiomyopathy patients and highly related to changes in ventricular function
por: Ortega, Ana, et al.
Publicado: (2016) -
COVID-19 and Heart Transplantation. Initial Experience in a Tertiary Hospital
por: López-Vilella, Raquel, et al.
Publicado: (2021) -
ASB1 differential methylation in ischaemic cardiomyopathy: relationship with left ventricular performance in end‐stage heart failure patients
por: Ortega, Ana, et al.
Publicado: (2018)